Seno Medical and Genetik, Inc. signed a distribution collaboration to advertise, distribute, and provide service for Genetik, Inc.'s breakthrough, Imagio Opto-Acoustic/Ultrasound (OA/US) Breast Imaging System.
To increase the volume of contrast media production, GE Healthcare has committed USD 80 million. The growth in the API is an important step towards increasing the supply of ionizing contrast media, as its components are vital to the manufacturing process.
Author Credits: Radhika Gupta, Shivam Bhutani
Report ID: 4917
Published Date: May 02, 2023
Report Format: PDF, PPT
Frequently Asked Questions (FAQ)
Increasing incidences of chronic diseases, and the growing application of contrast agents in healthcare are the major factors driving the market growth.
The market size of contrast media is anticipated to attain a CAGR of 6.70% over the forecast period, i.e., 2023-2035.
Lack of trained professionals and the side effects of contrast agents are estimated to be the growth hindering factors for the market expansion.
The market in the North American region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.
The major players in the market are Bayer AG, General Electric Company, Guerbet, Bracco Diagnostic, Inc., Trivitron Healthcare, Nano Therapeutics Pvt. Ltd., iMax, Lantheus Medical Imaging, Inc., Beijing Beilu Pharmaceuticals Company Limited, SANOCHEMIA Pharmazeutika GmbH
The company profiles are selected based on the revenues generated from the product segment, the geographical presence of the company which determines the revenue-generating capacity, and the new products being launched into the market by the company.
The market is segmented by modality, product type, application, and by region.
The iodinated contrast media segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.